Cost analysis of a disease management programme for adult Medicaid clients with schizophrenia

Grant H. Skrepnek, Edward P Armstrong, Katie Brookler, John Roper, Beth E. Martin, Laurel Karabatsos, Christy Hunter

Research output: Contribution to journalArticle

Abstract

This investigation assessed changes in direct medical costs, from the perspective of a public payer, associated with a comprehensive, field-based disease management programme for adult Medicaid clients with schizophrenia in the US State of Colorado. A propensity score-matching algorithm was employed in this retrospective analysis owing to the inherent non-randomisation of enrollees. Of the 126 clients initially enrolled, 73 (58%) remained within the programme continuously for 6-12 months. These participants were associated with 30% lower overall per member per month medical costs (p<0.001), although no differences were noted for overall pharmacy costs. Provision of the disease management programme was through an external vendor and cost $31,250 per month regardless of the number enrolled. Future research should seek to assess long-term clinical, humanistic and economic outcomes in this population and to develop methods that increase programme participation.

Original languageEnglish (US)
Pages (from-to)411-426
Number of pages16
JournalJournal of Medical Economics
Volume10
Issue number4
DOIs
StatePublished - 2007

Fingerprint

Medicaid
Disease Management
Schizophrenia
Costs and Cost Analysis
Propensity Score
Economics
Population

Keywords

  • Disease management
  • Medicaid
  • Pharmacoeconomics
  • Schizophrenia
  • United States

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Cost analysis of a disease management programme for adult Medicaid clients with schizophrenia. / Skrepnek, Grant H.; Armstrong, Edward P; Brookler, Katie; Roper, John; Martin, Beth E.; Karabatsos, Laurel; Hunter, Christy.

In: Journal of Medical Economics, Vol. 10, No. 4, 2007, p. 411-426.

Research output: Contribution to journalArticle

Skrepnek, Grant H. ; Armstrong, Edward P ; Brookler, Katie ; Roper, John ; Martin, Beth E. ; Karabatsos, Laurel ; Hunter, Christy. / Cost analysis of a disease management programme for adult Medicaid clients with schizophrenia. In: Journal of Medical Economics. 2007 ; Vol. 10, No. 4. pp. 411-426.
@article{05667d58e1874f3aa270c466b80d0fde,
title = "Cost analysis of a disease management programme for adult Medicaid clients with schizophrenia",
abstract = "This investigation assessed changes in direct medical costs, from the perspective of a public payer, associated with a comprehensive, field-based disease management programme for adult Medicaid clients with schizophrenia in the US State of Colorado. A propensity score-matching algorithm was employed in this retrospective analysis owing to the inherent non-randomisation of enrollees. Of the 126 clients initially enrolled, 73 (58{\%}) remained within the programme continuously for 6-12 months. These participants were associated with 30{\%} lower overall per member per month medical costs (p<0.001), although no differences were noted for overall pharmacy costs. Provision of the disease management programme was through an external vendor and cost $31,250 per month regardless of the number enrolled. Future research should seek to assess long-term clinical, humanistic and economic outcomes in this population and to develop methods that increase programme participation.",
keywords = "Disease management, Medicaid, Pharmacoeconomics, Schizophrenia, United States",
author = "Skrepnek, {Grant H.} and Armstrong, {Edward P} and Katie Brookler and John Roper and Martin, {Beth E.} and Laurel Karabatsos and Christy Hunter",
year = "2007",
doi = "10.3111/13696990701617016",
language = "English (US)",
volume = "10",
pages = "411--426",
journal = "Journal of Medical Economics",
issn = "1369-6998",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Cost analysis of a disease management programme for adult Medicaid clients with schizophrenia

AU - Skrepnek, Grant H.

AU - Armstrong, Edward P

AU - Brookler, Katie

AU - Roper, John

AU - Martin, Beth E.

AU - Karabatsos, Laurel

AU - Hunter, Christy

PY - 2007

Y1 - 2007

N2 - This investigation assessed changes in direct medical costs, from the perspective of a public payer, associated with a comprehensive, field-based disease management programme for adult Medicaid clients with schizophrenia in the US State of Colorado. A propensity score-matching algorithm was employed in this retrospective analysis owing to the inherent non-randomisation of enrollees. Of the 126 clients initially enrolled, 73 (58%) remained within the programme continuously for 6-12 months. These participants were associated with 30% lower overall per member per month medical costs (p<0.001), although no differences were noted for overall pharmacy costs. Provision of the disease management programme was through an external vendor and cost $31,250 per month regardless of the number enrolled. Future research should seek to assess long-term clinical, humanistic and economic outcomes in this population and to develop methods that increase programme participation.

AB - This investigation assessed changes in direct medical costs, from the perspective of a public payer, associated with a comprehensive, field-based disease management programme for adult Medicaid clients with schizophrenia in the US State of Colorado. A propensity score-matching algorithm was employed in this retrospective analysis owing to the inherent non-randomisation of enrollees. Of the 126 clients initially enrolled, 73 (58%) remained within the programme continuously for 6-12 months. These participants were associated with 30% lower overall per member per month medical costs (p<0.001), although no differences were noted for overall pharmacy costs. Provision of the disease management programme was through an external vendor and cost $31,250 per month regardless of the number enrolled. Future research should seek to assess long-term clinical, humanistic and economic outcomes in this population and to develop methods that increase programme participation.

KW - Disease management

KW - Medicaid

KW - Pharmacoeconomics

KW - Schizophrenia

KW - United States

UR - http://www.scopus.com/inward/record.url?scp=38149032862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38149032862&partnerID=8YFLogxK

U2 - 10.3111/13696990701617016

DO - 10.3111/13696990701617016

M3 - Article

VL - 10

SP - 411

EP - 426

JO - Journal of Medical Economics

JF - Journal of Medical Economics

SN - 1369-6998

IS - 4

ER -